Table 1 Paediatric patients admitted with COVID-19
N° | Age Range (years) | Sex | Past medical history | Clinical presentation | Laboratory findings | Infiltrates in X-ray or CT | Treatment | Co-Infections | Complications b) | MIS-C | Outcome | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Respiratory Symptoms | Gastrointestinal Symptoms | Other Symptoms | Max. CRP (mg/dl) | Max. D-Dimer (μg/ml) | Max. Troponin (ng/ml) | PICU treatment | Oxygen support | Invasive ventilation | Pharmaco-logical treatment b) | |||||||||
1 | < 1 | m | Healthy | X | X | Neg | NA | NA | NA | None | None | Complete recovery | |||||||
2 | ≥ 16 | w | Kidney transplantation 2008, immunosuppressive treatment | X | X | X | 38 | 50 | 507 | Yes | X | X | X | Antibiotic, antifungal, heparin | None | Pneumonia, pleural effusion, acute renal failure, hypertension | X | Complete recovery | |
3 | ≥ 16 | m | Hypoplastic left heart syndrome | X | Hypoxaemia | 15 | 6 | Neg | No | X | X | None | None | Cerebral vasculitis, myocarditis | X | Died 11 days after discharge | |||
4 | 6–12 | m | Oesophageal atresia, recurrent otitis media, multiple interventions | X | X | Orbital swelling | 16 | 5 | Neg | NA | Antibiotic | NA | None | Mild residual symptoms | |||||
5 = 15 | 6–12 | m | Rhabdomyosarcoma, cytotoxic chemotherapy | X | 5 | Neg | Neg | NA | Antibiotic | None | None | Complete recovery, Reinfection | |||||||
6 | 6–12 | w | Healthy | X | X | X | 16 | 5 | 14 | Yes | X | Antibiotic, heparin, defibrotide | None | Terminal ileitis, pneumonia, polyserositis | X | Complete recovery | |||
7 | ≥ 16 | w | Severe immunodeficiency syndrome with T-cell-disorder, HSCT 2019 | X | X | X | 14 | 1 | Neg | Yes | X | Antibiotic, antifungal, ribavirin, valganciclovir | Throat swab: HSV-1, CMV, EBV, HHV-6, Enterobacter cloacae | Pneumonia, pericardial effusion | X | Complete recovery | |||
8 | < 1 | w | Healthy | Livid discoloration of the legs | 2 | 2 | NA | NA | None | NA | None | Mild residual symptoms | |||||||
9 | 6–12 | w | Asthma, obesity | X | X | Neg | Neg | Neg | NA | Inhaled beta-2-mimetics | NA | None | Complete recovery | ||||||
10 | 13–15 | m | Sickle cell anaemia, Asthma | X | Haematuria | 6 | 7 | Neg | No | Xa) | Antibiotic, heparin | NA | None | Mild residual symptoms | |||||
11 | 13–15 | m | Healthy | X | X | X | Haemat-emesis | 13 | 1 | Neg | Yes | Antibiotic, heparin | Sputum: Streptococcus pneumoniae | Bacterial pneumonia | Mild residual symptoms | ||||
12 | < 1 | m | Healthy | X | X | Neg | NA | NA | NA | Antibiotic | None | None | complete recovery | ||||||
13 | 1–2 | w | Chronic Bronchitis | X | X | 2,5 | Neg | Neg | NA | None | NA | None | complete recovery | ||||||
14 | ≥ 16 | w | Liver transplantation 2019, immunosuppressive treatment | X | X | 6 | NA | NA | NA | None | NA | None | complete recovery | ||||||
15 = 5 | 6–12 | m | Rhabdomyosarcoma, cytotoxic chemotherapy | X | Neg | Neg | Neg | NA | None | NA | None | Mild residual symptoms | |||||||